{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T00:17:35Z","timestamp":1791591455998,"version":"4.3.4"},"reference-count":67,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004564","name":"Ministarstvo Prosvete, Nauke i Tehnolo\u0161kog Razvoja","doi-asserted-by":"publisher","award":["451-03-68\/2020-14\/200019"],"award-info":[{"award-number":["451-03-68\/2020-14\/200019"]}],"id":[{"id":"10.13039\/501100004564","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Placenta"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.placenta.2021.02.007","type":"journal-article","created":{"date-parts":[[2021,2,15]],"date-time":"2021-02-15T23:34:54Z","timestamp":1613432094000},"page":"51-57","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Macrophage migration inhibitory factor in human early pregnancy events and association with placental pathologies"],"prefix":"10.1016","volume":"116","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8292-4853","authenticated-orcid":false,"given":"Milica","family":"Jovanovi\u0107 Krivoku\u0107a","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksandra","family":"Viloti\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivana","family":"Stefanoska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u017danka","family":"Boji\u0107-Trbojevi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ljiljana","family":"Vi\u0107ovac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.placenta.2021.02.007_bib1","doi-asserted-by":"crossref","first-page":"514","DOI":"10.3181\/00379727-111-27841","article-title":"In vitro cell migration as a model for delayed hypersensitivity","volume":"111","author":"George","year":"1962","journal-title":"Proc. Soc. Exp. Biol. Med."},{"issue":"3731","key":"10.1016\/j.placenta.2021.02.007_bib2","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1126\/science.153.3731.80","article-title":"Mechanism of a reaction in vitro associated with delayed-type hypersensitivity","volume":"153","author":"Bloom","year":"1966","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.placenta.2021.02.007_bib3","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1073\/pnas.56.1.72","article-title":"Delayed hypersensitivity in vitro: its mediation by cell-free substances formed by lymphoid cell-antigen interaction","volume":"51","author":"David","year":"1966","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"19","key":"10.1016\/j.placenta.2021.02.007_bib4","doi-asserted-by":"crossref","first-page":"7522","DOI":"10.1073\/pnas.86.19.7522","article-title":"Molecular cloning of a cDNA encoding a human macrophage migration inhibitory factor","volume":"86","author":"Weiser","year":"1989","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"6866","key":"10.1016\/j.placenta.2021.02.007_bib5","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1038\/414920a","article-title":"MIF regulates innate immune responses through modulation of Toll-like receptor 4","volume":"414","author":"Roger","year":"2001","journal-title":"Nature"},{"issue":"6544","key":"10.1016\/j.placenta.2021.02.007_bib6","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/377068a0","article-title":"MIF as a glucocorticoid-induced modulator of cytokine production","volume":"377","author":"Calandra","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.placenta.2021.02.007_bib7","doi-asserted-by":"crossref","first-page":"7849","DOI":"10.1073\/pnas.93.15.7849","article-title":"An essential regulatory role for macrophage migration inhibitory factor in T-cell activation","volume":"93","author":"Bacher","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"7","key":"10.1016\/j.placenta.2021.02.007_bib8","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/s41584-019-0238-2","article-title":"The immunobiology of MIF: function, genetics and prospects for precision medicine","volume":"15","author":"Kang","year":"2019","journal-title":"Nat. Rev. Rheumatol."},{"issue":"12","key":"10.1016\/j.placenta.2021.02.007_bib9","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1080\/14728222.2016.1251582","article-title":"MIF, a controversial cytokine: a review of structural features, challenges, and opportunities for drug development","volume":"20","author":"Bloom","year":"2016","journal-title":"Expert Opin. Ther. Targets"},{"issue":"6308","key":"10.1016\/j.placenta.2021.02.007_bib10","doi-asserted-by":"crossref","first-page":"aad6872","DOI":"10.1126\/science.aad6872","article-title":"A nuclease that mediates cell death induced by DNA damage and poly(ADP-ribose) polymerase-1","volume":"354","author":"Wang","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.placenta.2021.02.007_bib11","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.cellsig.2019.01.006","article-title":"Evolving complexity of MIF signaling","volume":"57","author":"Jankauskas","year":"2019","journal-title":"Cell. Signal."},{"key":"10.1016\/j.placenta.2021.02.007_bib12","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.molmet.2018.10.001","article-title":"Phenotyping of circulating extracellular vesicles (EVs) in obesity identifies large EVs as functional conveyors of Macrophage Migration Inhibitory Factor","volume":"18","author":"Amosse","year":"2018","journal-title":"Mol. Metab."},{"issue":"1","key":"10.1016\/j.placenta.2021.02.007_bib13","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1677\/joe.0.1760103","article-title":"Macrophage migration inhibitory factor expression is increased in pituitary adenoma cell nuclei","volume":"176","author":"Pyle","year":"2003","journal-title":"J. Endocrinol."},{"issue":"8","key":"10.1016\/j.placenta.2021.02.007_bib14","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1093\/protein\/9.8.631","article-title":"The subunit structure of human macrophage migration inhibitory factor: evidence for a trimer","volume":"9","author":"Sun","year":"1996","journal-title":"Protein Eng. Des. Sel."},{"issue":"5","key":"10.1016\/j.placenta.2021.02.007_bib15","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.it.2019.03.002","article-title":"Rediscovering MIF: new tricks for an old cytokine","volume":"40","author":"Harris","year":"2019","journal-title":"Trends Immunol."},{"issue":"Suppl","key":"10.1016\/j.placenta.2021.02.007_bib16","doi-asserted-by":"crossref","first-page":"S51","DOI":"10.1016\/j.placenta.2013.10.015","article-title":"Review: putative roles for the macrophage migratory inhibitory factor at the maternal fetal interface","volume":"35","author":"Bevilacqua","year":"2014","journal-title":"Placenta"},{"issue":"2","key":"10.1016\/j.placenta.2021.02.007_bib17","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1093\/humrep\/14.2.395","article-title":"Induction of macrophage migration inhibitory factor in human ovary by human chorionic gonadotrophin","volume":"14","author":"Wada","year":"1999","journal-title":"Hum. Reprod."},{"issue":"6","key":"10.1016\/j.placenta.2021.02.007_bib18","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1095\/biolreprod60.6.1299","article-title":"Expression of macrophage migration inhibitory factor transcript and protein by first-trimester human trophoblasts","volume":"60","author":"Arcuri","year":"1999","journal-title":"Biol. Reprod."},{"issue":"4","key":"10.1016\/j.placenta.2021.02.007_bib19","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1095\/biolreprod64.4.1200","article-title":"Macrophage migration inhibitory factor in the human endometrium: expression and localization during the menstrual cycle and early pregnancy","volume":"64","author":"Arcuri","year":"2001","journal-title":"Biol. Reprod."},{"issue":"1","key":"10.1016\/j.placenta.2021.02.007_bib20","doi-asserted-by":"crossref","first-page":"E272","DOI":"10.1152\/ajpendo.00086.2006","article-title":"Oxygen regulation of macrophage migration inhibitory factor in human placenta","volume":"292","author":"Ietta","year":"2007","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.placenta.2021.02.007_bib21","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1006\/abbi.1993.1257","article-title":"The major binding protein of the interferon antagonist sarcolectin in human placenta is a macrophage migration inhibitory factor","volume":"303","author":"Zeng","year":"1993","journal-title":"Arch. Biochem. Biophys."},{"issue":"4","key":"10.1016\/j.placenta.2021.02.007_bib22","first-page":"805","article-title":"Macrophage migration inhibitory factor in the human ovary: presence in the follicular fluids and production by granulosa cells","volume":"41","author":"Wada","year":"1997","journal-title":"Biochem. Mol. Biol. Int."},{"issue":"12","key":"10.1016\/j.placenta.2021.02.007_bib23","doi-asserted-by":"crossref","first-page":"3518","DOI":"10.1093\/humrep\/dei234","article-title":"Cycle-dependent expression of macrophage migration inhibitory factor in the human endometrium","volume":"20","author":"Kats","year":"2005","journal-title":"Hum. Reprod."},{"issue":"1","key":"10.1016\/j.placenta.2021.02.007_bib24","doi-asserted-by":"crossref","DOI":"10.1111\/aji.13064","article-title":"Cervico-vaginal secretion cytokine profile: a non-invasive approach to study the endometrial receptivity in IVF cycles","volume":"81","author":"Zanotta","year":"2019","journal-title":"Am. J. Reprod. Immunol."},{"issue":"3","key":"10.1016\/j.placenta.2021.02.007_bib25","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1095\/biolreprod.106.054189","article-title":"Differential regulation of colony stimulating factor 1 and macrophage migration inhibitory factor expression by inflammatory cytokines in term human decidua: implications for macrophage trafficking at the fetal-maternal interface","volume":"76","author":"Arcuri","year":"2007","journal-title":"Biol. Reprod."},{"issue":"2","key":"10.1016\/j.placenta.2021.02.007_bib26","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s00281-007-0074-3","article-title":"The role of macrophage migration inhibitory factor in maintaining the immune privilege at the fetal-maternal interface","volume":"29","author":"Vigan\u00f2","year":"2007","journal-title":"Semin. Immunopathol."},{"issue":"1","key":"10.1016\/j.placenta.2021.02.007_bib27","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s00404-005-0109-8","article-title":"Macrophage migration inhibition factor is elevated in pregnancy, but not to a greater extent in preeclampsia","volume":"274","author":"Hristoskova","year":"2006","journal-title":"Arch. Gynecol. Obstet."},{"issue":"2","key":"10.1016\/j.placenta.2021.02.007_bib28","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.placenta.2014.12.003","article-title":"Pharmacological inhibition of MIF interferes with trophoblast cell migration and invasiveness","volume":"36","author":"Jovanovi\u0107 Krivoku\u0107a","year":"2015","journal-title":"Placenta"},{"issue":"6","key":"10.1016\/j.placenta.2021.02.007_bib29","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1034\/j.1600-0897.2002.01152.x","article-title":"Macrophage migration inhibitory factor in human pregnancy and labor","volume":"48","author":"Ietta","year":"2002","journal-title":"Am. J. Reprod. Immunol."},{"issue":"3","key":"10.1016\/j.placenta.2021.02.007_bib30","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1093\/humrep\/deg147","article-title":"Decreased serum levels of macrophage migration inhibition factor in miscarriages with normal chromosome karyotype","volume":"18","author":"Yamada","year":"2003","journal-title":"Hum. Reprod."},{"issue":"1","key":"10.1016\/j.placenta.2021.02.007_bib31","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.humimm.2004.10.002","article-title":"Constitutive intracellular expression of human leukocyte antigen (HLA)-DO and HLA-DR but not HLA-DM in trophoblast cells","volume":"66","author":"Ranella","year":"2005","journal-title":"Hum. Immunol."},{"issue":"9","key":"10.1016\/j.placenta.2021.02.007_bib32","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1093\/molehr\/2.9.685","article-title":"Hyaluronan, CD44 and its variant exons in human trophoblast invasion and placental angiogenesis","volume":"2","author":"Goshen","year":"1996","journal-title":"Mol. Hum. Reprod."},{"issue":"1","key":"10.1016\/j.placenta.2021.02.007_bib33","doi-asserted-by":"crossref","first-page":"12150","DOI":"10.1038\/s41598-018-29797-6","article-title":"Role of the Macrophage Migration Inhibitory Factor (MIF) in the survival of first trimester human placenta under induced stress conditions","volume":"8","author":"Ietta","year":"2018","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.placenta.2021.02.007_bib34","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1046\/j.1365-2249.2000.01149.x","article-title":"HIV-1 co-receptor expression on trophoblastic cells from early placentas and permissivity to infection by several HIV-1 primary isolates","volume":"119","author":"Mognetti","year":"2000","journal-title":"Clin. Exp. Immunol."},{"issue":"10","key":"10.1016\/j.placenta.2021.02.007_bib35","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1290\/0404033.1","article-title":"Interleukin-8 can stimulate progesterone secretion from a human trophoblast cell line, BeWo, in Vitro Cell","volume":"40","author":"Tsui","year":"2004","journal-title":"Dev. Biol. Anim."},{"issue":"1","key":"10.1016\/j.placenta.2021.02.007_bib36","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/j.1600-065X.2011.01040.x","article-title":"Innate and adaptive immune responses to cell death","volume":"243","author":"Rock","year":"2011","journal-title":"Immunol. Rev."},{"issue":"11","key":"10.1016\/j.placenta.2021.02.007_bib37","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1007\/BF03401765","article-title":"Involvement of macrophage migration inhibitory factor (MIF) in the mechanism of tumor cell growth","volume":"4","author":"Takahashi","year":"1998","journal-title":"Mol. Med."},{"issue":"3","key":"10.1016\/j.placenta.2021.02.007_bib38","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/BF03402061","article-title":"An essential role for macrophage migration inhibitory factor (MIF) in angiogenesis and the growth of a murine lymphoma","volume":"5","author":"Chesney","year":"1999","journal-title":"Mol. Med."},{"key":"10.1016\/j.placenta.2021.02.007_bib39","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.placenta.2016.03.001","article-title":"Macrophage migration inhibitory factor induces phosphorylation of Mdm2 mediated by phosphatidylinositol 3-kinase\/Akt kinase: role of this pathway in decidual cell survival","volume":"41","author":"Costa","year":"2016","journal-title":"Placenta"},{"issue":"3","key":"10.1016\/j.placenta.2021.02.007_bib40","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1006\/bbrc.1999.1584","article-title":"High expression of macrophage migration inhibitory factor in human melanoma cells and its role in tumor cell growth and angiogenesis","volume":"264","author":"Shimizu","year":"1999","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.placenta.2021.02.007_bib41","doi-asserted-by":"crossref","DOI":"10.1071\/RD20138","article-title":"Macrophage Migration Inhibitory Factor (MIF) modulates cytokine expression in the trophoblast cell line HTR-8\/SVneo","author":"Jovanovi\u0107 Krivoku\u0107a","year":"2020","journal-title":"Reprod. Fertil. Dev."},{"issue":"4","key":"10.1016\/j.placenta.2021.02.007_bib42","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1161\/01.RES.0000087641.56024.DA","article-title":"Migration inhibitory factor mediates angiogenesis via mitogen-activated protein kinase and phosphatidylinositol kinase","volume":"93","author":"Amin","year":"2003","journal-title":"Circ. Res."},{"issue":"12","key":"10.1016\/j.placenta.2021.02.007_bib43","doi-asserted-by":"crossref","first-page":"E403","DOI":"10.1210\/jc.2010-0417","article-title":"Macrophage migration inhibitory factor elicits an angiogenic phenotype in human ectopic endometrial cells and triggers the production of major angiogenic factors via CD44, CD74, and MAPK signaling pathways","volume":"95","author":"Veillat","year":"2010","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"Suppl 1","key":"10.1016\/j.placenta.2021.02.007_bib44","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.2119\/molmed.2015.00055","article-title":"25 Years on: a retrospective on migration inhibitory factor in tumor angiogenesis","volume":"21","author":"Chesney","year":"2015","journal-title":"Mol. Med."},{"issue":"6","key":"10.1016\/j.placenta.2021.02.007_bib45","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1182\/blood-2005-05-2011","article-title":"Migration inhibitory factor up-regulates vascular cell adhesion molecule-1 and intercellular adhesion molecule-1 via Src, PI3 kinase, and NF\u03baB","volume":"107","author":"Amin","year":"2006","journal-title":"Blood"},{"issue":"9\u201310","key":"10.1016\/j.placenta.2021.02.007_bib46","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.placenta.2005.12.006","article-title":"The uterine spiral arteries in human pregnancy: facts and controversies","volume":"27","author":"Pijnenborg","year":"2006","journal-title":"Placenta"},{"issue":"3","key":"10.1016\/j.placenta.2021.02.007_bib47","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1080\/19336918.2017.1386822","article-title":"N-cadherin knockdown leads to disruption of trophoblastic and endothelial cell interaction in a 3D cell culture model\u2013New insights in trophoblast invasion failure","volume":"12","author":"Multhaup","year":"2018","journal-title":"Cell Adhes. Migrat."},{"issue":"9","key":"10.1016\/j.placenta.2021.02.007_bib48","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1172\/JCI119387","article-title":"Human cytotrophoblasts adopt a vascular phenotype as they differentiate: a strategy for successful endovascular invasion?","volume":"99","author":"Zhou","year":"1997","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.placenta.2021.02.007_bib49","first-page":"DOC1007","article-title":"Macrophage migration inhibitory factor is involved in endovascular trophoblast cell function in vitro","volume":"18","author":"Viloti\u0107","year":"2019","journal-title":"EXCLI J."},{"issue":"5","key":"10.1016\/j.placenta.2021.02.007_bib50","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1007\/s15010-017-1031-2","article-title":"Human infectious diseases and risk of preeclampsia: an updated review of the literature","volume":"45","author":"Nourollahpour Shiadeh","year":"2017","journal-title":"Infection"},{"issue":"4","key":"10.1016\/j.placenta.2021.02.007_bib51","doi-asserted-by":"crossref","first-page":"715","DOI":"10.2298\/ABS151123012J","article-title":"MIF is among the proinflammatory cytokines increased by LPS in the human trophoblast line","volume":"68","author":"Jovanovi\u0107-Krivoku\u0107a","year":"2016","journal-title":"Arch. Biol. Sci."},{"issue":"6","key":"10.1016\/j.placenta.2021.02.007_bib52","doi-asserted-by":"crossref","first-page":"2792","DOI":"10.1016\/j.ajpath.2011.02.005","article-title":"Effect of macrophage migration inhibitory factor (MIF) in human placental explants infected with toxoplasma gondii depends on gestational age","volume":"178","author":"De Oliveira Gomes","year":"2011","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.placenta.2021.02.007_bib53","doi-asserted-by":"crossref","first-page":"852","DOI":"10.3389\/fmicb.2019.00852","article-title":"Increased toxoplasma gondii intracellular proliferation in human extravillous trophoblast cells (HTR8\/SVneo Line) is sequentially triggered by MIF, ERK1\/2, and COX-2","volume":"10","author":"Milian","year":"2019","journal-title":"Front. Microbiol."},{"issue":"3","key":"10.1016\/j.placenta.2021.02.007_bib54","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.placenta.2013.12.013","article-title":"Susceptibility to Toxoplasma gondii proliferation in BeWo human trophoblast cells is dose-dependent of macrophage migration inhibitory factor (MIF), via ERK1\/2 phosphorylation and prostaglandin E2 production","volume":"35","author":"Barbosa","year":"2014","journal-title":"Placenta"},{"key":"10.1016\/j.placenta.2021.02.007_bib55","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.3389\/fimmu.2019.01300","article-title":"Recruitment of MAIT cells to the intervillous space of the placenta by placenta-derived chemokines","volume":"10","author":"Solders","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.placenta.2021.02.007_bib56","first-page":"639342","article-title":"Macrophage migration inhibitory factor in fetoplacental tissues from preeclamptic pregnancies with or without fetal growth restriction","author":"Cardaropoli","year":"2012","journal-title":"Clin. Dev. Immunol."},{"issue":"2","key":"10.1016\/j.placenta.2021.02.007_bib57","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.ejogrb.2005.03.014","article-title":"Increased levels of macrophage migration inhibitory factor (MIF) in preeclampsia","volume":"123","author":"Todros","year":"2005","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"issue":"7","key":"10.1016\/j.placenta.2021.02.007_bib58","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1089\/jir.2013.0057","article-title":"Lower macrophage migration inhibitory factor concentrations in maternal serum before pre-eclampsia onset","volume":"34","author":"Cardaropoli","year":"2014","journal-title":"J. Interferon Cytokine Res."},{"key":"10.1016\/j.placenta.2021.02.007_bib59","doi-asserted-by":"crossref","first-page":"804519","DOI":"10.1155\/2014\/804519","article-title":"The role of MIF in type 1 and type 2 diabetes mellitus","volume":"2014","author":"S\u00e1nchez-Zamora","year":"2014","journal-title":"J. Diabetes. Res."},{"key":"10.1016\/j.placenta.2021.02.007_bib60","doi-asserted-by":"crossref","first-page":"308","DOI":"10.3389\/fimmu.2015.00308","article-title":"Role of macrophage migration inhibitory factor in obesity, insulin resistance, type 2 diabetes, and associated hepatic Co-morbidities: a comprehensive review of human and rodent studies","volume":"6","author":"Morrison","year":"2015","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.placenta.2021.02.007_bib61","doi-asserted-by":"crossref","first-page":"76","DOI":"10.3109\/09513590.2011.588757","article-title":"Macrophage migration-inhibitory factor is elevated in pregnant women with gestational diabetes mellitus","volume":"28","author":"Yilmaz","year":"2012","journal-title":"Gynecol. Endocrinol."},{"issue":"12","key":"10.1016\/j.placenta.2021.02.007_bib62","first-page":"198366","article-title":"Unbiased placental secretome characterization identifies candidates for pregnancy complications","author":"Napso","year":"2020","journal-title":"bioRxiv"},{"issue":"8","key":"10.1016\/j.placenta.2021.02.007_bib63","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1055\/s-0031-1275706","article-title":"Genetic variation in macrophage migration inhibitory factor associated with gestational diabetes mellitus and metabolic syndrome","volume":"43","author":"Aslani","year":"2011","journal-title":"Horm. Metab. Res."},{"issue":"1","key":"10.1016\/j.placenta.2021.02.007_bib64","doi-asserted-by":"crossref","first-page":"797","DOI":"10.4238\/2015.February.2.4","article-title":"Association between macrophage migration inhibitory factor rs1007888 and GDM","volume":"14","author":"Zhan","year":"2015","journal-title":"Genet. Mol. Res."},{"issue":"2","key":"10.1016\/j.placenta.2021.02.007_bib65","doi-asserted-by":"crossref","first-page":"206.E1","DOI":"10.1016\/j.ajog.2008.08.022","article-title":"Global placental gene expression in gestational diabetes mellitus","volume":"200","author":"Enquobahrie","year":"2009","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"12","key":"10.1016\/j.placenta.2021.02.007_bib66","doi-asserted-by":"crossref","first-page":"2951","DOI":"10.2337\/diabetes.52.12.2951","article-title":"Gestational diabetes induces placental genes for chronic stress and inflammatory pathways","volume":"52","author":"Radaelli","year":"2003","journal-title":"Diabetes"},{"issue":"2","key":"10.1016\/j.placenta.2021.02.007_bib67","doi-asserted-by":"crossref","first-page":"323","DOI":"10.4149\/neo_2020_190321N255","article-title":"Macrophage migration inhibitory factor is differentially expressed in normal and choriocarcinoma trophoblast cells","volume":"67","author":"Vilotic","year":"2020","journal-title":"Neoplasma"}],"container-title":["Placenta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0143400421000503?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0143400421000503?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T18:05:32Z","timestamp":1758909932000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0143400421000503"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":67,"alternative-id":["S0143400421000503"],"URL":"https:\/\/doi.org\/10.1016\/j.placenta.2021.02.007","relation":{},"ISSN":["0143-4004"],"issn-type":[{"value":"0143-4004","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Macrophage migration inhibitory factor in human early pregnancy events and association with placental pathologies","name":"articletitle","label":"Article Title"},{"value":"Placenta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.placenta.2021.02.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}